Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
TargetMol | Compound Library

Bioactive Compounds Library Max

Catalog No. L4010

Bioactive Compound Library Max is a collection of 26421 compounds with biological activity that elicit biological responses in cells, tissues and even individuals. It includes drug molecules that are in preclinical studies, clinical-phase studies and those that are already on the market. With clear targets and comprehensive information, it is ideal for drug repurposing, cell induction and differentiation, and protein target identification in biochemical mechanistic studies.

Because of the clear activity and known targets, many scientists will select small molecules from the Bioactive Compound Library that can be used for cell induction and differentiation. By the combined actions of a single or several small molecules, molecules capable of inducing various somatic cells into induced pluripotent stem cells, neural precursor cells, cardiomyocytes, etc. have been screened; there have even been successful trials of induced differentiation in vivo using combinations of small molecules.

The Bioactive Compound Library Max is a more extensive version of the Bioactive Compound Library (L4000), with the addition of TargetMol's unique and novel compounds (Part B), all of which have clear targets and have been tested for activity at the cellular level. Therefore, it has more novel structures than approved drug libraries and leads to easier active compounds discovery than drug-like compound libraries.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

Resource Download
Library compound info
Excel
SDF
Contact us for more batch information

Catalog No. L4010

Bioactive Compounds Library Max

sizeIn stock

  • 1 mg
  • 30 μL x 10 mM (in DMSO)
  • 50 μL x 10 mM (in DMSO)
  • 100 μL x 10 mM (in DMSO)
  • 250 μL x 10 mM (in DMSO)
Inquiry & Custom

Top Publication Citing
Use of TargetMol Products

Cite scientific literature on TargetMol products

View More

Packaging And Storage Packaging And Storage

  • Powder or pre-dissolved DMSO solutions in 96/384 well plate with optional 2D barcode
  • Shipped with blue ice
  • This compound library is provided at a concentration of 10 mM in DMSO. A small number of compounds may be provided in different solvents or concentrations due to solubility or stability requirements. Please refer to the specific product information for details.

Product Description Product Description

  • A collection of 26421 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.
  • All compounds are described with corresponding target information, which makes activity studies more evidence-based.
  • An effective tool for drug repurposing and cell-induced target screening.
  • Covers multiple areas of disease studies, such as cancer, metabolism, immune system and cardiovascular system.
  • Detailed instructions, compound structures, target information, activity descriptions, etc.
  • Structural diversity, significant drug potency and cell penetration.

Advantages Introduction Advantages Introduction

High-Standard Entry Criteria

TargetMol's Bioactive Compounds Library Max is established upon rigorous entry standards to ensure that every compound included is structurally well-defined and of exceptional purity, verified through multiple analytical techniques such as NMR, HPLC, and LC-MS. Our multi-layered screening mechanism effectively eliminates compounds with ambiguous structures, such as mixtures and polymers. Moreover, we specifically exclude substances like sunscreens, contrast agents, dyes, fragrances, plastic additives, and intermediates—compounds typically lacking biological activity due to their specificity and stability, which generally prevent interactions with biological systems. This meticulous curation reduces time and resource waste caused by ineffective screenings. To further enhance hit rates in activity screening, we have introduced TargetMol’s exclusive novel compounds (Part B), all of which have well-defined targets and have undergone activity testing at both cellular and protein levels.

Significant Structural Diversity

TargetMol’s Bioactive Compounds Library Max features extensive scaffold diversity and structural complexity, offering a substantial advantage in drug discovery. Based on the Bemis-Murcko scaffold classification, our library is categorized into 15,111 unique classes, each representing a distinct molecular scaffold, thereby extensively covering a broad chemical space. The compounds range from simple to highly complex structures, providing a diverse foundation for identifying lead compounds with strong affinity and specificity toward target proteins. This structural richness significantly advances pharmaceutical innovation. Whether targeting traditional drug targets or emerging, more challenging ones, our Bioactive Compounds Library Max offers a wealth of candidate molecules to accelerate the drug development process.

 Bioactive Compounds Library Max
Library Diversity Analysis

Superior Drug-Like Properties

73% of the compounds in TargetMol's Bioactive Compounds Library Max comply with Lipinski’s "Rule of Five" (Ro5), indicating excellent bioavailability and permeability.

 Bioactive Compounds Library Max  Bioactive Compounds Library Max
 Bioactive Compounds Library Max  Bioactive Compounds Library Max
 Bioactive Compounds Library Max  Bioactive Compounds Library Max

Multidimensional Pharmacokinetic Analysis

A multidimensional evaluation is conducted on TargetMol’s Bioactive Compounds Library Max, which systematically analyzes three key pharmacological parameters: blood-brain barrier permeability, cardiotoxicity (HERG K+ channel inhibition), and oral absorption performance.

 Bioactive Compounds Library Max  Bioactive Compounds Library Max  Bioactive Compounds Library Max

15% of the compounds can cross the blood-brain barrier, while 85% cannot.
58% of the compounds exhibit cardiotoxicity, while 42% do not.
60% of the compounds are highly orally absorbable, 28% are orally absorbable, and 12% are poorly orally absorbable.

Diverse Compound Collection

TargetMol’s Bioactive Compounds Library Max encompasses a wide range of molecule types with diverse biological activities. This includes approved drugs, clinical trial candidates, literature-reported bioactive compounds, and molecules capable of eliciting responses at the cellular, tissue, or even whole-organism level. The library covers not only major signaling pathways and targets but also many emerging therapeutic targets. The Bioactive Compounds Library Max (L4010) is established upon the classic L4000 library by adding approximately 300 new targets, bringing the total to nearly 900 targets across about 4,000 receptors. This significantly enhances the likelihood of successful screening hits. The library spans a broad spectrum of therapeutic areas, including cancer, cardiovascular diseases, and neurological disorders.

 Bioactive Compounds Library Max  Bioactive Compounds Library Max
 Bioactive Compounds Library Max  Bioactive Compounds Library Max

Regular Updates to Compound Libraries

We ensure our compound libraries remain at the forefront of scientific research by regularly updating our database with compounds mentioned in cutting-edge literature and newly custom-synthesized compounds.

Flexible Packaging Options

We offer a variety of standard packaging sizes (e.g., 30 μL, 50 μL, 100 μL, 250 μL, 1 mg), and we can customize packaging solutions to meet specific needs.

Customized Services

To support specific needs, we offer tailored screening services, including the design and synthesis of customized compound libraries and the execution of personalized screening projects. Our highly flexible service model is designed to efficiently meet unique needs of scientists and accelerate breakthrough discoveries.

Library Customization | TargetMol Library Customization

Compound Library | TargetMol
Targetmol Compound Libraries
can be highly customized!
Inquiry & Custom

Sci Citations

Library Customization | TargetMol Library Composition

Apoptosis
Antibacterial
Endogenous Metabolite
Autophagy
Antibiotic
5-HT Receptor
Antifungal
AChR
Adrenergic Receptor
Parasite
DNA/RNA Synthesis
COX
NF-κB
Dopamine Receptor
CDK
Calcium Channel
Potassium Channel
HIV Protease
Antioxidant
PI3K
EGFR
Cytochromes P450
Histamine Receptor
Epigenetic Reader Domain
Dehydrogenase
Sodium Channel
PDE
GABA Receptor
VEGFR
Reactive Oxygen Species
GluR
Histone Methyltransferase
TRP/TRPV Channel
Influenza Virus
PPAR
Microtubule Associated
HDAC
TNF
Wnt/beta-catenin
Cholinesterase (ChE)
Phosphatase
JAK
Akt
mTOR
Topoisomerase
GPCR
p38 MAPK
Prostaglandin Receptor
Antiviral
ERK
Estrogen/progestogen Receptor
Ferroptosis
Src
SARS-CoV
PKC
NMDAR
FLT
Adenosine Receptor
PARP
RAAS
Estrogen Receptor/ERR
HCV Protease
IL Receptor
STAT
Nucleoside Antimetabolite/Analog
iGluR
Opioid Receptor
PDGFR
AMPK
Caspase
FGFR
MMP
Virus Protease
Glucocorticoid Receptor
Bcl-2 Family
GSK-3
Androgen Receptor
NO Synthase
MAO
Raf
ROS
TLR
Lipoxygenase
HSP
c-Kit
ATPase
Cannabinoid Receptor
Bcr-Abl
c-Met/HGFR
ALK
Phospholipase
TGF-beta/Smad
Beta Amyloid
HBV
Tyrosinase
Proteasome
Sirtuin
Mitochondrial Metabolism
MAPK
HSV
Drug Metabolite
Nrf2
Anti-infection
Ras
HIF/HIF Prolyl-Hydroxylase
Integrin
Histone Demethylase
DUB
JNK
NOS
p53
Tyrosine Kinases
Aurora Kinase
Immunology/Inflammation related
Mitophagy
PKA
CCR
PROTACs
E1/E2/E3 Enzyme
ROCK
Carbonic Anhydrase
Transferase
Antifection
P-gp
MEK
HIF
Casein Kinase
Gamma-secretase
Interleukin
IκB/IKK
Monoamine Oxidase
Reverse Transcriptase
Cysteine Protease
Retinoid Receptor
S1P Receptor
Norepinephrine
Serotonin Transporter
RIP kinase
CXCR
P2X Receptor
Serine/threonin kinase
Neurokinin receptor
Reductase
Glucosidase
IGF-1R
c-RET
Serine Protease
LPL Receptor
FAK
NOD
DNA-PK
Hedgehog/Smoothened
Histone Acetyltransferase
TAM Receptor
Sigma receptor
Fatty Acid Synthase
ATM/ATR
FAAH
CaMK
Glucokinase
S6 Kinase
PERK
Trk receptor
transporter
HER
Progesterone Receptor
ribosome
NADPH
Amino Acids and Derivatives
c-Fms
HMG-CoA Reductase
Chloride channel
Proton pump
DPP-4
PLK
Syk
CFTR
Acyltransferase
Pim
DNA Methyltransferase
Mdm2
Endothelin Receptor
Rho
DNA
Chk
Protease-activated Receptor
Kinesin
Thrombin
Glucagon Receptor
AhR
cAMP
DHFR
Aryl Hydrocarbon Receptor
LTR
P2Y Receptor
IRAK
Thyroid hormone receptor(THR)
Cholecystokinin Receptor
Smo
DNA Alkylator/Crosslinker
FXR
STING
PD-1/PD-L1
ROR
Leukotriene Receptor
LPA Receptor
Lipase
DYRK
LRRK2
Hydroxylase
ADC Cytotoxin
YAP
SGLT
PDK
Complement System
MRP
BTK
Factor Xa
Glutathione Peroxidase
Guanylate cyclase
BACE
OX Receptor
Indoleamine 2,3-Dioxygenase (IDO)
c-Myc
Vasopressin Receptor
Platelet aggregation
DNA Alkylation
Xanthine Oxidase
Neuropeptide Y Receptor
Kras
Liver X Receptor
Aromatase
Epoxide Hydrolase
PAK
Ephrin Receptor
IAP
RSV
Ligand for E3 Ligase
IRE1
ROS Kinase
PGE Synthase
NOD-like Receptor (NLR)
GTPase
Myosin
Antifolate
Photosensitizer
Melanocortin Receptor
CSF-1R
LDL
Bradykinin Receptor
ABC Transporter
Molecular Glues
Telomerase
PI4K
GNRH Receptor
Monoamine Transporter
Lipid
GPCR19
NADPH-oxidase
Neurotensin Receptor
Glutaminase
PAI-1
GHSR
Beta-Secretase
Monocarboxylate transporter
Free radical scavengers
Acetyl-CoA Carboxylase
MicroRNA
Aminopeptidase
CaSR
Arrestin
DNA gyrase
IFNAR
IDO
Stearoyl-CoA Desaturase (SCD)
PAFR
Somatostatin
Discoidin Domain Receptor (DDR)
NAMPT
Isocitrate Dehydrogenase (IDH)
GPX
GRK
Phosphorylase
Ligands for Target Protein for PROTAC
MNK
PKM
Neprilysin
OAT
MLK
UGT
BCRP
Imidazoline Receptor
IKZF
Arginase
Na+/Ca2+ Exchanger
Melatonin Receptor
ATP Citrate Lyase
Porcupine
Bcl-6
MT Receptor
SGK
Apelin receptor
Dynamin
LIM Kinase
Angiotensin-converting Enzyme (ACE)
Wee1
GST
Carboxypeptidase
Gap Junction Protein
Tie-2
AAK1
SIK
PTEN
OCT
Bombesin Receptor
Protease
APC/C
Adenylyl Cyclase
GlyT
PAD
ASK
CRFR
Oxytocin Receptor
Melanin-concentrating Hormone Receptor (MCHR)
MyD88
Amylase
MAGL
CGRP Receptor
NR4A
cGAS
TSH Receptor
Annexin A
MIF
PYK2
Survivin
Methionine Adenosyltransferase (MAT)
p97
CAT
HCN Channel
MELK
TOPK
FLAP
Decarboxylase
Adenosine Deaminase
MALT
MTP
OXPHOS
Pyroptosis
CRISPR/Cas9
CRM1
DAPK
Succinate Receptor 1 (SUCNR1)
Neuropeptide FF Receptor
RAR/RXR
DprE1
MRGPR
NEDD8
ATG
CD73
Hippo pathway
Cell wall
CETP
ACK1
Galectin
Cell Cycle Arrest
MTH1
Orphan Receptor
Aquaporin
BMI-1
gp120/CD4
AIM2
NPC1L1
LDLR
FOXO
CD38
VDAC
Adiponectin Receptor
p62
Advanced Glycation End Products
Hck
RANKL/RANK
FOXO3
Hexokinase
Thrombopoietin Receptor
PGK1
Vitamin
ASCT
CPT
Glutathione reductase
FABP
KSP
Cadherin
GluCls
Factor VIIa
Necroptosis
Na-K-Cl cotransporter
PSMA
HuR
Haspin Kinase
NEDD4-1
KLF
Liposome
Transaminase
GSNOR
EBI2/GPR183
Taste receptor
E3 Ligase Ligand-Linker Conjugate
Integrase
Prolyl Endopeptidase (PREP)
PACAP
Huntingtin
FKBP
RXFP receptor
GDNF
VDA
PROTAC Linker
Transketolase
ADC Linker
NUDIX hydrolase
Piezo Channel
Fas/FasL
hCE
Lysosomal Autophagy
ATTECs
Glyoxalase
ASBT
Glutaminyl Cyclase
OLIG2
Y Box Binding Protein 1
REV-ERB
MDM-2/p53
Aconitase
Motilin Receptor
Thioredoxin
Neuropeptide W
stilbene oxidase
N-Acetylglucosaminyltransferase
Photosystem (PS)
Endonuclease
Anion Exchanger
glycosidase
CD74
Procollagen C Proteinase
Stemness kinase
TMV
NMU2R
Enteropeptidase (EP)
CYP19A1
B7
HCAR
Fer/FerT kinase
Tight Junction Protein
MAP3K
Mucin
Urea Transporter
Cuproptosis
Chemerin Receptor
Ferroportin
IGF-2R
Sodium-dependent phosphate transporter
PGC-1α
PARG(Poly(ADP-ribose) Glycohydrolase)
Poly(ADP-ribose) Glycohydrolase (PARG)

Keywords